Select Your Language : |
The One Stop For all Your Regulatory Requirements
 
Forth Coming Events : Stall at CPHI – Paris (World Wide) - IP 12 ; Forth Coming Events Stall at CPHI – India – G-43
Regulatory Submissions
Our Representative render the following services in respective countries :
Countries - Vietnam, Cambodia, Mynamar, kenya, Uganda, Tanzania, GCC countries – Saudi Arabia, Kuwait, Bahrain, Qatar, UAE, Oman, Yemen. CIS countries – Kyrgyzstan, Uzbekistan, Turkmenistan, Georgia, Tajikistan, Belarus, Kazakhstan, Azerbaijan, Ukraine, Russia.
Render the following Services
>
Company registration.
> Brand search.
> Preparing the dossier in English and respective languages.
> Handling query if any on your behalf.
> Get the registration of pharmaceutical product.

Disclaimer

All information and material in this site are provided on an "as is" basis, and are without guarantees or warranties of any kind, express or implied. Furthermore, any ideas and/or information provided or gained from this site would not necessarily reflect the views of Labela Regsources or its directors or employees.

The materials and/or information available or obtained at/through this site is/are not guaranteed or warranted in terms of completeness, correctness, accuracy, reliability or otherwise howsoever by Labela Regsources or its directors or employees.

NIL LIABILITY
Under no circumstances, including but not limited to negligence, shall Labela Regsources or its directors or employees be liable for any special or consequential damages that are alleged to have resulted from the use and/or inability to use this site or information contained within, even if Labela Regsources and/or its employees or directors have been notified of the possibilities of potential damages or losses.

In no case shall Labela Regsources or its directors or employees be liable to any person or entity for any damages or losses resulting either directly or indirectly from accessing this site. The information provided herein and any communications subsequently entertained or responded to are/shall be gratis an are/shall be outside the purview of any consumer protection law. Any recipient or user of any information or material in this site may use/rely upon the information or material entirely at his/its own risk.

The contents of this site shall not be reproduced, distributed or published in whole or in part by the recipient hereof or any other person for any purpose without the prior written approval of Labela Regsources.

 
 
 
Dossier compilation as per:
> Common technical dossier    (CTD) format
> Asean Common Technical    Dossier (ACTD) Guidelines > South Africa (MCC-MRF-1)    Guidelines.
> Brazil ANVISA Guidelines
 
Dossiers compilation for submissions in:
> Asia
 
> Africa  
> Central  America  
> South  America  
> North  America  
> CIS countries
 
Drug master file (DMF) compilation for open and closed parts
 
 
> Expert report
> Overview - Clinical / Non-
   clinical
> Periodic Safety Update
   report (PSUR)
> Validation
> Bioequivalence Studies
> Clinical Trial Report
  Our area of expertise
 
Data base of regulatory requirements of more than 100 countries & for more than 5000 molecules. Speedy compilation of Dossiers for Regulated and Semi Regulated markets.

 Regulatory submissions, Liaison with Regulatory       boards and follow-ups.

*    Complete regulatory support till the registration       stage.

*    Reports on Bioavailability / Bioequivalance Studies,       Clinical Trials studies boards and follow-ups.

*    Draft data for Process Validation, Analytical
   Validation, Stability Studies report, Dissolution       profile, Certificate of analysis and related reports.


*   Prepare Periodic Safety Update report (PSUR) to      fulfill CIS registration dossier requirements.

*   Prepare Summary of product (SPC), Pack Insert,      Product rationale to fulfill registration dossier      requirements.

*   Expert Reports – Quality, Pre-clinical, Clinical to fulfill      CTD registration dossier requirements.

*   Overviews - Clinical / Non-Clinical to fulfill CTD      registration dossier requirements.

*   Liaison for Process Validation, Analytical Validation,      Stability Studies and related reports.

*   Reports on Preclinical studies like Toxicity,      Carcinogenicity, Teratology  and Reproduction      toxicity.

 Liaison for Bioavailability / Bioequivalance Studies,      Clinical trials report and related reports for CTD,      Geneva, TGA – Australia, Medsafe –  New Zealand      and Brazil – ANVISA .

*    Dossier conversion (from one country to another)

*    Registration Assistance.

*    Drug master file (DMF) compilation for open and       closed parts.
Disclaimer
Website Design & Mantained by Ambestmedia
 
Home Services Clients Registration Contact
Home Services Clients Registration Contact